This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Franklin D. Schwartz, MD

Arch Intern Med. 1978;138(11):1612-1613.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A minoglycoside antibiotics are widely used in treatment of serious Gram-negative infections. In addition, they are used in combination with penicillins to treat enterococcal infections and with penicillinase-resistant penicillins or cephalosporins for staphylococcal infections.

Currently available aminoglycoside antibiotics include streptomycin, neomycin, paromomycin, gentamicin, tobramycin, and amikacin. Several newer compounds are still under investigation.

Unlike other antibiotics, such as penicillin, therapeutic levels of the aminoglycosides are perilously close to toxic levels—the therapeutic index is small. Further, selection of the optimal dosage is difficult because of considerable variation from subject to subject, both in peak blood levels produced by a given dose and also in serum half-life of the antibiotic.^1-3

This problem is magnified for patients with renal insufficiency and even further exaggerated for those receiving long-term hemodialysis. A number of approaches have been proposed for dosage determination in the presence of reduced renal function. Most utilize various forms of equations . . . [Full Text PDF of this Article]

Author Affiliations
740 Rush St Chicago, IL 60611

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?